Pressmeddelande

ExpreS2ion annual report for 2023 published

Cision Publicerad: 08 May 12:05

Hørsholm, Denmark, 8 May 2024 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby announces that the company's annual report for the financial year 2023 is published. The annual report is available as an attachment and on ExpreS2ion's website at the following address (https://investor.expres2ionbio.com/reports/).

The Swedish version of the Annual Report is the version that the Company’s Auditors have reviewed, as clarified in the Auditor’s Report included at the end of the report. As such, in the case of differences between the Swedish and English versions, the Swedish version prevails.

Certified Adviser
Svensk Kapitalmarknadsgranskning AB

Bifogade filer

240508 EXPRS2 PR Annual Report 2023https://mb.cision.com/Main/14402/3975784/2786101.pdf

2023 Årsredovisning - ExpreS2ion Biotech Holding ABhttps://mb.cision.com/Public/14402/3975784/be9ed774bfff407c.pdf

2023 Annual Report - ExpreS2ion Biotech Holding ABhttps://mb.cision.com/Public/14402/3975784/bacf0ca07dcdbb83.pdf

Nyheter om ExpreS2ion Biotech

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!